RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 79.35
-1.35 (-1.67%)
Sep 1, 2026, 4:08 PM HKT
RemeGen Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 8,000 | 3,242 | 1,710 | 1,076 | 767.78 | 1,424 |
Other Revenue | 6.61 | 9.49 | 6.71 | 6.82 | 4.33 | - |
| 8,006 | 3,251 | 1,717 | 1,083 | 772.11 | 1,424 | |
Revenue Growth | 286.21% | 89.36% | 58.54% | 40.26% | -45.77% | - |
Cost of Revenue | 491.57 | 415.49 | 346.72 | 257.27 | 272.05 | 67.16 |
Gross Profit | 7,515 | 2,836 | 1,370 | 825.68 | 500.06 | 1,357 |
Selling, General & Admin | 1,626 | 1,476 | 1,265 | 1,079 | 707.01 | 482.81 |
Research & Development | 985.68 | 1,219 | 1,540 | 1,306 | 982.08 | 710.97 |
Other Operating Expenses | 5.38 | -0.85 | -14.92 | -22.56 | -13.53 | 41.23 |
Operating Expenses | 2,616 | 2,696 | 2,795 | 2,371 | 1,686 | 1,235 |
Operating Income | 4,899 | 139.86 | -1,425 | -1,545 | -1,186 | 121.61 |
Interest Expense | -46 | -70.17 | -72.38 | -23.09 | -6.76 | -5.32 |
Interest & Investment Income | 13.72 | 4.59 | 10.24 | 35.12 | 73.65 | 43.35 |
Currency Exchange Gain (Loss) | -10.01 | 0.93 | -7.13 | 1.53 | 13.23 | -25.47 |
Other Non Operating Income (Expenses) | 9.11 | 1.32 | -6.79 | -4.58 | -0.77 | 142.62 |
EBT Excluding Unusual Items | 4,866 | 76.53 | -1,501 | -1,536 | -1,107 | 276.79 |
Gain (Loss) on Sale of Investments | 960.52 | 636.28 | -2.76 | - | - | -0.22 |
Gain (Loss) on Sale of Assets | -2.45 | -0.91 | -0.93 | -0.79 | -1.02 | -0.31 |
Other Unusual Items | -1.12 | -1.5 | 36.07 | 25.97 | 108.84 | 0 |
Pretax Income | 5,823 | 710.4 | -1,468 | -1,511 | -998.83 | 276.26 |
Income Tax Expense | 1.34 | 0.75 | - | - | - | - |
Net Income | 5,822 | 709.65 | -1,468 | -1,511 | -998.83 | 276.26 |
Net Income to Common | 5,822 | 709.65 | -1,468 | -1,511 | -998.83 | 276.26 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 559 | 550 | 538 | 540 | 531 | 487 |
Shares Outstanding (Diluted) | 560 | 550 | 538 | 540 | 531 | 487 |
Shares Change | 3.88% | 2.28% | -0.34% | 1.59% | 9.00% | 19.43% |
EPS (Basic) | 10.41 | 1.29 | -2.73 | -2.80 | -1.88 | 0.57 |
EPS (Diluted) | 10.39 | 1.29 | -2.73 | -2.80 | -1.88 | 0.57 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4,359 | -147.05 | -1,380 | -2,356 | -2,013 | -351.44 |
Free Cash Flow Per Share | 7.78 | -0.27 | -2.56 | -4.36 | -3.79 | -0.72 |
Gross Margin | 93.86% | 87.22% | 79.81% | 76.24% | 64.77% | 95.28% |
Operating Margin | 61.19% | 4.30% | -82.98% | -142.70% | -153.61% | 8.54% |
Profit Margin | 72.71% | 21.83% | -85.53% | -139.55% | -129.36% | 19.40% |
Free Cash Flow Margin | 54.44% | -4.52% | -80.36% | -217.51% | -260.74% | -24.68% |
EBITDA | 5,144 | 391.94 | -1,189 | -1,369 | -1,062 | 187.84 |
EBITDA Margin | 64.24% | 12.06% | -69.23% | -126.44% | -137.54% | 13.19% |
D&A For EBITDA | 244.45 | 252.08 | 236.05 | 176.12 | 124.03 | 66.24 |
EBIT | 4,899 | 139.86 | -1,425 | -1,545 | -1,186 | 121.61 |
EBIT Margin | 61.19% | 4.30% | -82.98% | -142.70% | -153.61% | 8.54% |
Effective Tax Rate | 0.02% | 0.10% | - | - | - | - |
Revenue as Reported | 8,006 | 3,251 | 1,717 | 1,083 | 772.11 | - |